Navigation Links
Boehringer Ingelheim to Purchase Amgen's Fremont (USA) Facility
Date:1/31/2011

SAN FRANCISCO, Jan. 31, 2011 /PRNewswire/ -- Global Real Estate Consultants has helped Boehringer Ingelheim to strengthen their global presence with a new facility in Fremont.

Global Real Estate Consultants was retained by Boehringer Ingelheim to provide insight and transparency in the Fremont commercial real estate market specifically related to their purchase of Amgen Inc's 350,000 sq. ft. state-of-the-art manufacturing facility with pilot plant and process development labs. "We looked for an international tenant representation specialist to help us undertake a real estate acquisition in a new geographical area. We chose Global Real Estate Consultants because we felt that their level of expertise would best represent our interest," states Dr. Maier-Erbacher of Boehringer Ingelheim.

"We provided Boehringer Ingelheim with unrivaled objective information and transparency," says founder and company principal Erich Struzyk. "At the end we were able to provide savings for our client which they initially did not expect. Boehringer Ingelheim especially appreciated the fact that we do not represent landlords and thus avoided the typical conflicts of interest inherent in the brokerage market."

About Boehringer Ingelheim

The Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 142 affiliates in 50 countries and more than 41,500 employees. For over 125 years, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2009, Boehringer Ingelheim posted net sales of 12.7 billion euro while spending 21% of net sales in its largest business segment, Prescription Medicines, on research and development (http://www.boehringer-ingelheim.com).

About Global Real Estate Consult
'/>"/>

SOURCE Global Real Estate Consultants
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Boehringer Ingelheim to Purchase Amgens Fremont (California) Facility
2. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
3. Boehringer Ingelheim Initiates Phase III Clinical Trial With Afatinib in Advanced Breast Cancer
4. Boehringer Ingelheims Pradaxa Available in U.S. Pharmacies Starting Wednesday, November 3
5. Results of Boehringer Ingelheim Oral Hepatitis C Protease Inhibitor and Polymerase Inhibitor Combination Phase Ib Trial Shows Rapid Viral Response Without Use of Pegylated Interferon
6. Boehringer Ingelheim and MacroGenics Announce Global Alliance to Discover, Develop and Commercialize DART™-Based Antibody Therapeutics
7. Boehringer Ingelheim Announces Pivotal Phase III Data Showing Linagliptin Reduced Blood Sugar Compared to Placebo in People With Type 2 Diabetes
8. -- Neurocrine Announces a Second Corporate Collaboration Within Twenty-Four Hours -- Neurocrine Biosciences Announces a Worldwide Collaboration With Boehringer Ingelheim to Research and Develop GPR119 Agonists for Type II Diabetes
9. Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010
10. New Boehringer Ingelheim Science Quest Mobile Laboratory Brings Hands-On Science Education to Priority Connecticut Elementary Schools
11. Reportlinker Adds Boehringer Ingelheim GmbH: PharmaVitae Profile
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2015)... June 25, 2015 ... announced the addition of the "2015 ... Global Challenges, Emerging Technologies, Competitive Landscape" ... New Frontiers in Clinical Chemistry and Immunodiagnostics: ... a new seven-country strategic analysis of major ...
(Date:7/2/2015)... NORTH CHICAGO, Ill. , July 2, 2015 /PRNewswire/ ... 2015 financial results on Friday, July 24, 2015, before ... live webcast of the earnings conference call at 8 ... accessible through AbbVie,s Investor Relations website at www.abbvieinvestor.com ... available after 11 a.m. Central time. About ...
(Date:7/2/2015)... July 2, 2015 Legal-Bay LLC, The Lawsuit ... Joseph Goodwin in the Southern District of ... transvaginal mesh cases against Ethicon for a single trial ... cases for the 26 women include claims from the ... made my Johnson & Johnson,s Ethicon subsidiary. The cases ...
Breaking Medicine Technology:New Frontiers in 2015 Global Clinical Chemistry and Immunodiagnostics Market: Challenges, Emerging Technologies, Competitive Landscape 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Sets Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3
... Pa., June 17, 2011 Inovio Pharmaceuticals, Inc. (NYSE ... subsidiary VGX Animal Health, Inc., a developer of DNA-based ... achieved strong T cell responses from VAH-5000D, its DNA ... of dogs with cancer. This preclinical data was presented ...
... HeartWare International, Inc. (NASDAQ: HTWR - ... circulatory support technologies that are revolutionizing the treatment of ... is scheduled to make an investor presentation at the ... Time on Wednesday, June 22, 2011.  The conference is ...
Cached Medicine Technology:VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 2VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 3VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival 4HeartWare to Present at the Wells Fargo 2011 Healthcare Conference 2
(Date:7/2/2015)... ... ... Many Fourth of July celebrations will include fireworks this summer, so it’s ... some tips to promote the proper use of fireworks. , According to the U.S. ... with fireworks-related injuries in the month surrounding the Fourth of July. Amica is sharing ...
(Date:7/2/2015)... ... 02, 2015 , ... Get ready to hit the gym, ... the socks were first introduced, they have rapidly been gaining attention among active ... new, fun shades including: blue, lime, pink and red. , Utilizing innovative ...
(Date:7/2/2015)... ... July 02, 2015 , ... When ... met for the late June Web-based session, the speakers discussed the importance of ... managing high-risk patients through coordinated care. , During the session, participants learned the ...
(Date:7/2/2015)... ... July 02, 2015 , ... Real Time Pain Relief (RTPR), makers of ... with Big Sky PBR to sponsor The Fifth Annual Big Sky Professional Bull ... will offer product samples of their popular pain relief lotion and products at the family ...
(Date:7/2/2015)... ... July 02, 2015 , ... eHuman Digital Anatomy, the industry ... their flagship product, 3D Tooth Atlas, version 7.6. This release delivers new and ... videos. This latest release of the 3D Tooth Atlas offers a much faster ...
Breaking Medicine News(10 mins):Health News:6 Fireworks Safety Tips from Amica Insurance 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 2Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 3Health News:ACO Coalition Discusses the Future of Medicare Payments and the Benefits of Providing More Care 4Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 2Health News:Real Time Pain Relief Sponsors The Fifth Annual Big Sky Professional Bull Riders Event at Big Sky Town Center in July 3Health News:eHuman Digital Anatomy Releases 3D Tooth Atlas version 7.6 2
... application records informs research , , FREMONT, Calif., ... NCCC ) research reveals that children ... risk of the most common form of childhood leukemia. , , ... database unique to California to reveal an elevated risk in acute lymphoblastic ...
... , , MINNEAPOLIS, Sept. 24 ... cervical cancer screening program sponsored by the NorthPoint Heath & Wellness ... the Cure(R) - Minnesota Affiliate, will be held at the North ... 7, and 8. Appointments are being scheduled from 8:30 a.m. to ...
... , SAN FRANCISCO, Sept. 24 Volcano Corporation ... manufacturing and sales of products for the diagnosis and treatment ... from PROSPECT, the landmark 700 patient natural history study sponsored ... the progression of cardiovascular disease via precise, intravascular imaging, and ...
... , SALT LAKE CITY, Sept. 24 Dynatronics Corporation (Nasdaq: ... to its nationwide direct sales force, bringing the total to 50 - ... thrilled to be adding so many experienced representatives to our sales team," ... Dynatronics. "This is just one more way we,re benefiting from the ...
... EMERYVILLE, Calif., Sept. 24 Onyx Pharmaceuticals, Inc. ... webcast an investor briefing on Wednesday, September 30, 2009, beginning ... for Nexavar in breast cancer presented at the 15th European ... (ESMO) Multidisciplinary Congress in Berlin. , , ...
... C.S. Mott Children,s Hospital National Poll on Children,s Health ... against H1N1 flu, despite higher disease risk; Hispanic parents more likely to ... With schools back in session, H1N1 flu has become more active ... H1N1 flu -- strongly recommended for kids -- has been tested and ...
Cached Medicine News:Health News:Northern California Cancer Center Finds Increased Risk of Most Common Form of Childhood Leukemia Associated With Residential Proximity to Agricultural Pesticides 2Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 2Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 3Health News:Free Upcoming Program Scheduled to Help Remove Barriers To Early Cervical and Breast Cancer Diagnosis for Local Women 4Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 2Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 3Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 4Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 5Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 6Health News:Results From Landmark PROSPECT Trial Demonstrate the Ability of Volcano's VH(R) IVUS Imaging to Identify Plaques Most Likely to Cause Heart Attacks 7Health News:Dynatronics Expands Nationwide Direct Sales Force by 25 Percent 2Health News:H1N1 Flu: Are Parents Underestimating Risk to Kids? 2Health News:H1N1 Flu: Are Parents Underestimating Risk to Kids? 3Health News:H1N1 Flu: Are Parents Underestimating Risk to Kids? 4
Torso Brief Bodysuit V-BA85...
A One Piece Support Garment - any length or size...
Body Suit w/Bra above knee...
Ideal for chest procedures....
Medicine Products: